Pharmacologic modulation of fetal hemoglobin.
Steinberg
M H
MH
Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA. msteinberg@medicine.bu.edu
Rodgers
G P
GP
D000755:Anemia, Sickle Cell / Q000188:drug therapy* / Q000503:physiopathology; D000986:Antisickling Agents / Q000494:pharmacology; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D004912:Erythrocytes / Q000502:physiology; D005319:Fetal Hemoglobin / Q000096:biosynthesis / Q000494:pharmacology*; D005786:Gene Expression Regulation; D006801:Humans; D006918:Hydroxyurea / Q000494:pharmacology; D007223:Infant; D007231:Infant, Newborn; D017086:beta-Thalassemia / Q000188:drug therapy* / Q000503:physiopathology
D000986:Antisickling Agents; D005319:Fetal Hemoglobin; D006918:Hydroxyurea